Cloricromen hydrochloride

Overview

Cloricromen (Cloricromene) hydrochloride is an orally active platelet inhibitor. Cloricromen hydrochloride inhibits thromboxane B 2 release, β-thromboglobulin , and thrombus formation. Cloricromen hydrochloride inhibits LPS ( HY-D1056 )-induced NF-κB activation, oxidative activity, and TNF-α expression. Cloricromen hydrochloride exhibits protective activity in animal models of shock and peripheral ischaemia. Cloricromen hydrochloride can be used for the research of myocardial ischaemia/reperfusion injury, and ischaemic cerebrovascular disease.

Application

Products | Products > Disease Areas > Nervous System Injury | Products > Disease Areas > Cardiovascular Disease | Products > Disease Areas > Ischemia-Reperfusion Injury | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Oxidative Stress and Inflammation | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > NF-κB | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > TNF Receptor | Products > Signaling Pathways > NF-κB

Product Information

• Catalog No.: HY-116678A
• CAS No.: 74697-28-2
• Molecular Formula: C20H27Cl2NO5
• Molecular Weight: 432.34
• Purity: 99.82%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: 2.5 mg/mL (5.78 mM); Clear solution; Need ultrasonic
• Availability: In-stock

Source

Original product source